Latest ESC-ESVS1 and SICVE2 Guidelines stated that in patients who are not at high risk for surgery, bypass is still indicated for long femoropopliteal lesions when an autologous vein is available. The autologous saphenous vein remains to be the conduit of choice.
Troisi, N., ASCOLI MARCHETTI, A., in LIMBSAVE, G. (2020). Contemporary outcomes of in-situ saphenous vein bypass in the endovascular era: update on LIMBSAVE registry. ITALIAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 27(3), 103-104 [10.23736/S1824-4777.20.01491-6].
Contemporary outcomes of in-situ saphenous vein bypass in the endovascular era: update on LIMBSAVE registry
Ascoli Marchetti Andrea;
2020-09-15
Abstract
Latest ESC-ESVS1 and SICVE2 Guidelines stated that in patients who are not at high risk for surgery, bypass is still indicated for long femoropopliteal lesions when an autologous vein is available. The autologous saphenous vein remains to be the conduit of choice.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
limbsave editorial italian journal vascular endovascular theraphy.pdf
solo utenti autorizzati
Descrizione: Articolo principale
Tipologia:
Versione Editoriale (PDF)
Licenza:
Copyright dell'editore
Dimensione
282.73 kB
Formato
Adobe PDF
|
282.73 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.